Abbott unveil BVS in IndiaIllustrative image – not actual.

US-based drugmaker Abbott has launched drug eluting bioresorbable vascular scaffold (BVS) in India for the treatment of coronary artery disease (CAD).

Abbott's BVS is made of polylactide, a naturally dissolvable material that is commonly used in medical implants such as dissolving sutures. The launch of this BVS is supported by a clinical trial program.

Source: Business Stander


 

← All latest storiesBack to top →